5-(2-Morpholin-4-yl-ethyl)-[1,3,4]thiadiazol-2-ylamine, 95.0%, 5g

Morpholine, min. 99%, for synthesis, 500 ml, glass packaging

2-Amino-4-cyanophenol, 95.0%, 5g

TERT-BUTYL 3-METHOXY-3-METHYLAZETIDINE-1-CARBOXYLATE, 95.0%, 1g

tert-Butyl (3-(5-aminonaphthalen-1-yl)propyl)carbamate, 97%, 50mg

2,2-Dimethoxypropane, 98.0%, 100ml

(3S,4S)-3-(N-BOC-N-METHYLAMINO)-4-METHYLPIPERIDINE, 95.0%, 100mg

1-(4-Methyl-benzyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole, 98%, 250mg

(2R,3S)-2-Amino-3-methoxybutanoic acid, 97%, 250mg

Sodium 2-oxo-2-phenylethanesulfonate, 97.0%, 250mg

2-Naphthalenemethanol, 97.0%, 500g

6-(Ethyl(3-isopropoxy-4-isopropylphenyl)amino)nicotinic acid, 95%, 1g

2-((7-Bromo-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)isoindoline-1,3-dione, 98%, 1g